[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30.
https://doi.org/10.3322/caac.21590
|
[3]
|
Xia, C., Dong, X., Li, H., et al. (2022) Cancer Statistics in China and United States, 2022: Profiles, Trends, and Determinants. Chinese Medical Journal, 135, 584-590. https://doi.org/10.1097/CM9.0000000000002108
|
[4]
|
李星, 曾晓勇. 中国前列腺癌流行病学研究进展[J]. 肿瘤防治研究, 2021, 48(1): 98-102.
|
[5]
|
Yagami, T., Yamamoto, Y. and Koma, H. (2018) Physiological and Pathologi-cal Roles of 15-Deoxy-δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases. Molecular Neurobiology, 55, 2227-2248.
https://doi.org/10.1007/s12035-017-0435-4
|
[6]
|
Hussain, T., Gupta, S. and Mukhtar, H. (2003) Cyclooxygenase-2 and Prostate Carcinogenesis. Cancer Letters, 191, 125-135. https://doi.org/10.1016/S0304-3835(02)00524-4
|
[7]
|
Gupta, S., Srivastava, M., Ahmad, N., Bostwick, D.G. and Mukhtar, H. (2000) Over-Expression of Cyclooxygenase-2 in Human Prostate Adenocarcinoma. The Prostate, 42, 73-78.
https://doi.org/10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G
|
[8]
|
Madrigal-Martínez, A., Constâncio, V., Lucio-Cazaña, F.J. and Fernández-Martínez, A.B. (2019) PROSTAGLANDIN E2 Stimulates Can-cer-Related Phenotypes in Prostate Cancer PC3 Cells through Cyclooxygenase-2. Journal of Cellular Physiology, 234, 7548-7559. https://doi.org/10.1002/jcp.27515
|
[9]
|
Miao, L., Grebhardt, S., Shi, J., et al. (2012) Prostaglandin E2 Stimulates S100A8 Expression by Activating Protein Kinase A and CCAAT/Enhancer-Binding-Protein-Beta in Prostate Cancer Cells. The International Journal of Biochemistry & Cell Biology, 44, 1919-1928. https://doi.org/10.1016/j.biocel.2012.06.015
|
[10]
|
Xu, S., Zhou, W., Ge, J. and Zhang, Z. (2018) Prostaglandin E2 Receptor EP4 Is Involved in the Cell Growth and Invasion of Prostate Cancer via the cAMPPKA/PI3KAkt Signaling Pathway. Molecular Medicine Reports, 17, 4702- 4712. https://doi.org/10.3892/mmr.2018.8415
|
[11]
|
Ching, M.M., Reader, J. and Fulton, A.M. (2020) Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Im-munotherapy. Frontiers in Pharmacology, 11, Article 819. https://doi.org/10.3389/fphar.2020.00819
|
[12]
|
Watanabe, K., Tominari, T., Hirata, M., et al. (2016) Abrogation of Prostaglandin E-EP4 Signaling in Osteoblasts Prevents the Bone Destruction Induced by Human Prostate Cancer Metas-tases. Biochemical and Biophysical Research Com- munications, 478, 154-161. https://doi.org/10.1016/j.bbrc.2016.07.075
|
[13]
|
Chen, H., Zhou, L., Wu, X., et al. (2016) The PI3K/AKT Pathway in the Pathogenesis of Prostate Cancer. Frontiers in Bioscience-Landmark, 21, 1084-1091. https://doi.org/10.2741/4443
|
[14]
|
Wang, W. and Wang, J. (2018) Toll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-κB Activation. Medical Science Monitor, 24, 5588-5597.
https://doi.org/10.12659/MSM.906857
|
[15]
|
Takahashi, R., Amano, H., Satoh, T., et al. (2014) Roles of Microso-mal Prostaglandin E Synthase-1 in Lung Metastasis Formation in Prostate Cancer RM9 Cells. Biomedicine & Pharma-cotherapy, 68, 71-77.
https://doi.org/10.1016/j.biopha.2013.10.008
|
[16]
|
O’Sullivan, A.G., Mulvaney, E.P., Hyland, P.B. and Kinsella, B.T. (2015) Protein Kinase C-Related Kinase 1 and 2 Play an Essential Role in Thromboxane-Mediated Neoplastic Re-sponses in Prostate Cancer. Oncotarget, 6, 26437- 26456. https://doi.org/10.18632/oncotarget.4664
|
[17]
|
Yoshimura, R., Sano, H., Masuda, C., et al. (2000) Expression of Cyclooxygenase-2 in Prostate Carcinoma. Cancer Letters, 89, 589-596. https://doi.org/10.1002/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C
|
[18]
|
Kirschenbaum, A., Klausner, A.P., Lee, R., et al. (2000) Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in the Human Prostate. Urology, 56, 671-676. https://doi.org/10.1016/S0090-4295(00)00674-9
|
[19]
|
Madaan, S., Abel, P.D., Chaudhary, K.S., et al. (2000) Cytoplasmic Induction and Over-Expression of Cyclooxygenase-2 in Human Prostate Cancer: Impli-cations for Prevention and Treatment. BJU International, 86, 736-741.
https://doi.org/10.1046/j.1464-410x.2000.00867.x
|
[20]
|
Lee, L.M., Pan, C.C., Cheng, C.J., Chi, C.W. and Liu, T.Y. (2001) Expression of Cyclooxygenase-2 in Prostate Adenocarcinoma and Benign Prostatic Hyperplasia. Anticancer Re-search, 21, 1291-1294.
|
[21]
|
Uotila, P., Valve, E., Martikainen, P., et al. (2001) Increased Expression of Cyclooxygen-ase-2 and Nitric Oxide Synthase-2 in Human Prostate Cancer. Urological Research, 29, 23-28. https://doi.org/10.1007/s002400000148
|
[22]
|
Fawzy, M.S., Elfayoumi, A.-R., Mohamed, R.H., et al. (2016) Cy-clooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians. Biochemical Genetics, 54, 326-336.
https://doi.org/10.1007/s10528-016-9722-4
|
[23]
|
Shao, N., Feng, N., Wang, Y., et al. (2012) Systematic Review and Meta-Analysis of COX-2 Expression and Polymorphisms in Prostate Cancer. Molecular Biology Reports, 39, 10997-11004.
https://doi.org/10.1007/s11033-012-2001-5
|
[24]
|
Shappell, S.B., Manning, S., Boeglin, W.E., et al. (2010) Altera-tions in Lipoxygenase and Cyclooxygenase-2 Catalytic Activity and mRNA Expression in Prostate Carcinoma. Neoplasia, 3, 287-303. https://doi.org/10.1038/sj.neo.7900166
|
[25]
|
Kirschenbaum, A., Liu, X.-H., Yao, S. and Levine, A.C. (2001) The Role of Cyclooxygenase-2 in Prostate Cancer. Urology, 58, 127-131. https://doi.org/10.1016/S0090-4295(01)01255-9
|
[26]
|
Niknami, M., Vignarajan, S., Yao, M., et al. (2010) Decrease in Expression or Activity of Cytosolic Phospholipase A2α Increases Cyclooxygenase-1 Action: A Cross-Talk between Key Enzymes in Arachidonic Acid Pathway in Prostate Cancer Cells. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 1801, 731-737.
https://doi.org/10.1016/j.bbalip.2010.03.003
|
[27]
|
Bin, W., He, W., Feng, Z., et al. (2011) Prognostic Relevance of Cyclooxygenase-2 (COX-2) Expression in Chinese Patients with Prostate Cancer. Acta Histochemica, 113, 131-136. https://doi.org/10.1016/j.acthis.2009.09.004
|
[28]
|
Flamiatos, J.F., Beer, T.M., Graff, J.N., et al. (2017) Cyclooxy-genase-2 (Cox-2) Inhibition for Prostate Cancer Chemoprevention: Double-Blind Randomised Study of Pre-Prostatectomy Celecoxib or Placebo. BJU International, 119, 709-716. https://doi.org/10.1111/bju.13612
|
[29]
|
Garg, R., Blando, J.M., Perez, C.J., et al. (2018) COX-2 Mediates Pro-Tumorigenic Effects of PKCε in Prostate Cancer. Oncogene, 37, 4735-4749. https://doi.org/10.1038/s41388-018-0318-9
|